Google, AHA create a $50M heart drug collaboration

Google Life Sciences ($GOOG) joined the American Heart Association in creating a new $50 million research initiative to find better heart drugs. The groups hope that a multidisciplinary approach to research can do a better job in discovering new cardio therapies, which remains a major challenge as biotechs assess the cost of developing new heart remedies. Story

Suggested Articles

Bayer's finerenone beat placebo at slowing kidney disease and cut the risk of heart attacks and strokes in diabetic kidney disease patients.

The National Institute of Allergy and Infectious Diseases is launching a new clinical trials network for COVID-19.

While Sanofi is looking to move more of its R&D in-house, there is still room for deals, and today it’s penned a big one with Fierce 15 winner Kymera